The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Private prescribing in the UK: what is actually involved

This is a generated summary. It shows the 9 most-liked posts from a topic of 77, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
SG
s.grimaldiTL217 Apr 2026#1

On the subject in the title: Private prescribing in the UK: what is actually involved Working notes rather than a conclusion.

The question about private prescribing that I actually want answered is the second one below. The first is context and I have kept it short.

Both are stated with units, and I have said what I already checked so that nobody repeats it.

27 likes 3mo
TK
t.kulkarniTL3Regular21 Apr 2026#2

Where the compound is supplied with a device, the device and the compound have separate availability positions and the device is more often the constraint.

29 likes 3mo
AA
a.adeyemiTL216 May 2026#16

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

The strength of my opinion here exceeds the strength of my evidence.

28 likes 2mo
AD
a.delgadoTL21 Jun 2026#28

Availability through a private route and availability through the public system are separate questions and both change independently.

26 likes 2mo
MH
m.haddadTL2Regular3 Jun 2026#29
BDraganov, post #6: Private prescribing is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring. Go to post

Private prescribing has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.

27 likes in reply to #6 2mo
ST
s.teixeiraTL222 Jun 2026#45
priorauth_notes, post #11: Where I part company with post #7, and it is a narrow parting. Counterpoint on private prescribing, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out. Go to post

Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating.

That is the practical version. The rigorous version is longer and says the same thing.

32 likes in reply to #11 1mo
BA
b.adeyemiTL229 Jun 2026#51
r.jhannsdttir, post #33: MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs. Go to post

I would rather this thread reach "we do not know" about private prescribing than reach a confident answer that nobody can support when asked.

30 likes in reply to #33 29d
I
IMainwaringTL3Regular12 Jul 2026#63

Private prescribing arrangements differ in what they include, and the differences are more consequential than the headline price.

28 likes 15d
KB
k.batistaTL220 Jul 2026#70

I had written a reply contradicting post #67 and deleted it. Here is what survived.

The most useful reply I ever got about private prescribing was a request to state my units. It sounds like pedantry and it has saved me twice.

27 likes 8d

Read the full topic (77 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
About the UK & Ireland category
MHRA positions, NHS pathways, private prescriptions, and Irish differences. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
SLHSJVIAK+3 7 357 3mo
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did. Asking about Pharmacy supply on behalf of the…
DBDATFHKD+46 53 14k 12mo
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. I was wrong about NHS criteria in a thread last spring and I would like to correct it…
AEUCRVTPAV+37 42 31k 2d
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…
APSRNVEOVF+10 14 27k 2d
UK access routes, dated and sourced
UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated June 2026, because everything in this category expires. The…
NROJC 2 5.8k 15mo

Related topics — sharing the tags personal import, cost per milligram, MHRA

TopicParticipantsRepliesViewsActivity
UK access routes, dated and sourced — a second dataset
Posting this under the heading it deserves: UK access routes, dated and sourced — a second dataset Everything below is what sits behind that. Regional question, dated January 2026, because everything in this…
EMGBSTYEM+76 82 25k 14mo
Pharmacy supply in the UK and the questions you will be asked
On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. Asking about pharmacy supply on behalf of the question I keep seeing asked…
CMCBRMNSP+95 105 1.3k 4mo
[2026 update] EU-wide position versus national implementation
On the subject in the title: EU-wide position versus national implementation Working notes rather than a conclusion. A methods question rather than a substantive one, about eu-wide position versus national…
FIANDT 2 54k 19mo
Comparing prices across jurisdictions without misleading yourself
Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. Working notes on comparing prices across jurisdictions rather than a…
LCGFVTPOO+78 83 33k 1mo
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. Asking what a regulator's document…
CRDPICCDJB+50 56 780 8mo